Carboplatin-paclitaxel- and carboplatin-docetaxel-induced cytotoxic effect in epithelial ovarian carcinoma in vitro
Open Access
- 15 November 1999
- Vol. 86 (10) , 2066-2073
- https://doi.org/10.1002/(sici)1097-0142(19991115)86:10<2066::aid-cncr26>3.0.co;2-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Early clinical studies with docetaxelEuropean Journal Of Cancer, 1995
- Preclinical pharmacology of docetaxelEuropean Journal Of Cancer, 1995
- Schedule-dependent synergism of taxol or taxotere with edatrexate against human breast cancer cells in vitroCancer Chemotherapy and Pharmacology, 1995
- Carboplatin versus cisplatinAnnals of Oncology, 1993
- Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cellsAnti-Cancer Drugs, 1992
- Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and-resistant human ovarian carcinoma cell linesCancer Chemotherapy and Pharmacology, 1992
- Relationships between the structure of taxol analogs and their antimitotic activityJournal of Medicinal Chemistry, 1991
- Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of TaxolJNCI Journal of the National Cancer Institute, 1991
- Short-termcis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cellsCancer Chemotherapy and Pharmacology, 1990